The regulatory standards for botanical raw materials are complex and vary significantly depending on the country and the intended use of the product, such as dietary supplements, food, cosmetics, or pharmaceuticals. In the United States, the Dietary Supplement Health and Education Act (DSHEA) places the primary responsibility for the safety of these materials on the manufacturer, with the FDA conducting post-market surveillance. The FDA does not require pre-approval for botanical raw materials used in dietary supplements, but manufacturers must adhere to Good Manufacturing Practices (GMPs) to ensure quality.

For pharmaceutical-grade botanicals, the regulations are more stringent, requiring extensive testing and FDA approval. The European Medicines Agency (EMA) has a more centralized approach to regulating botanical raw materials, with harmonized standards across EU member states. Globally, traceability, authentication, and testing for contaminants like pesticides and heavy metals are crucial aspects of compliance. Organizations such as the American Herbal Pharmacopoeia (AHP) and the United States Pharmacopeia (USP) offer voluntary standards for identity, purity, and potency.